Europe Favors “Mission-Oriented” Research in €100B Budget Proposal

The plan would also allow non-EU countries to pay to participate in EU research programs, albeit without wielding “decisional power.”

Written byCatherine Offord
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ISTOCK, ARTJAZZThe European Commission has outlined how it intends to divvy up €100 billion (about $120 billion USD) in research funding from 2021 to 2027. In documents published earlier last week (June 7), European policymakers laid out plans to dedicate a large slab to supporting research “focused around missions,” and to allow other countries, such as a post-Brexit Britain, to pay to take part in EU research programs.

Around €10 billion from the budget will be used for the new European Innovation Council, which has been set up to help to smooth the passage of basic research and technology from the lab to the marketplace. More than half of the overall budget is dedicated to what the proposal terms a “mission-oriented approach,” in which funding is allocated on the basis of desired outcome rather than research area. The outcomes are divided into five categories: health, inclusive and secure society, digital and industry, climate, energy and mobility, and food and natural resources.

Some policymakers view the new mission-driven approach as a way to make research more relevant to the public. In a statement, European Commissioner for Research, Science and Innovation Carlos Moedas says that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies